– Study is the Company’s first trial evaluating ability of M2SR and the current licensed standard of care to protect against drifted virus strains, and its second study in older… read more →
FluGen-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award from the UK’s innovation agency, the Technology Strategy Board Cambridge, UK – Arecor Ltd of Cambridge, England received the “green… read more →